Marilena Caresana

470 total citations
20 papers, 314 citations indexed

About

Marilena Caresana is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marilena Caresana has authored 20 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marilena Caresana's work include Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Marilena Caresana is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Acute Lymphoblastic Leukemia research (6 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Marilena Caresana collaborates with scholars based in Italy. Marilena Caresana's co-authors include Marina Boni, Paolo Bernasconi, Barbara Rocca, Ilaria Giardini, Silvia Calatroni, Paola Maria Cavigliano, Mario Lazzarino, Rita Zappatore, Catherine Klersy and Carlo Bernasconi and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and British Journal of Haematology.

In The Last Decade

Marilena Caresana

18 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilena Caresana Italy 10 276 131 89 53 48 20 314
Barbara Rocca Italy 9 274 1.0× 127 1.0× 86 1.0× 52 1.0× 48 1.0× 21 310
Paola Maria Cavigliano Italy 12 324 1.2× 136 1.0× 94 1.1× 69 1.3× 63 1.3× 27 384
Michael Heinsch Germany 8 267 1.0× 125 1.0× 88 1.0× 35 0.7× 26 0.5× 14 324
G.W. Dewald United States 9 329 1.2× 103 0.8× 147 1.7× 95 1.8× 61 1.3× 11 416
V. Parlier Switzerland 13 383 1.4× 144 1.1× 121 1.4× 100 1.9× 76 1.6× 19 446
Laurence Baranger France 12 244 0.9× 104 0.8× 110 1.2× 114 2.2× 49 1.0× 19 362
Magda Šišková Czechia 10 344 1.2× 131 1.0× 123 1.4× 32 0.6× 57 1.2× 22 395
Jörg Chromik Germany 7 279 1.0× 150 1.1× 109 1.2× 50 0.9× 18 0.4× 16 354
Simone Feurstein United States 10 249 0.9× 116 0.9× 81 0.9× 76 1.4× 95 2.0× 18 333
Chad P. Soupir United States 8 182 0.7× 92 0.7× 64 0.7× 46 0.9× 14 0.3× 9 304

Countries citing papers authored by Marilena Caresana

Since Specialization
Citations

This map shows the geographic impact of Marilena Caresana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilena Caresana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilena Caresana more than expected).

Fields of papers citing papers by Marilena Caresana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilena Caresana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilena Caresana. The network helps show where Marilena Caresana may publish in the future.

Co-authorship network of co-authors of Marilena Caresana

This figure shows the co-authorship network connecting the top 25 collaborators of Marilena Caresana. A scholar is included among the top collaborators of Marilena Caresana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilena Caresana. Marilena Caresana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Invernizzi, Rosangela, Marina Boni, Rita Zappatore, et al.. (2017). MDS/AML del(11)(q14) Share Common Morphological Features Despite Different Chromosomal Breakpoints. Anticancer Research. 37(2). 645–650. 1 indexed citations
2.
Rocca, Barbara, Catherine Klersy, Rita Zappatore, et al.. (2017). Alternative splicing of hTERT: a further mechanism for the control of active hTERT in acute myeloid leukemia. Leukemia & lymphoma. 59(3). 702–709. 6 indexed citations
3.
Boni, Marina, Marianna Rossi, Patrizia Zappasodi, et al.. (2012). Detection of TET2 abnormalities by fluorescence in situ hybridization in 41 patients with myelodysplastic syndrome. Cancer Genetics. 205(6). 285–294. 4 indexed citations
4.
Bernasconi, Paolo, Catherine Klersy, Barbara Rocca, et al.. (2012). Human Telomerase Reverse Transcriptase (hTERT): A New Potential Prognostic Marker in AML?. Blood. 120(21). 4790–4790.
5.
Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2010). Does cytogenetic evolution have any prognostic relevance in myelodysplastic syndromes? A study on 153 patients from a single institution. Annals of Hematology. 89(6). 545–551. 16 indexed citations
6.
Klersy, Catherine, Marina Boni, Paola Maria Cavigliano, et al.. (2007). Has Cytogenetic Evolution Any Prognostic Relevance in Myelodysplastic Syndromes (MDS)? A Study on 153 Patients.. Blood. 110(11). 2460–2460. 1 indexed citations
7.
Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2007). World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes. British Journal of Haematology. 137(3). 193–205. 64 indexed citations
8.
Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2007). Prognostic Significance of EVI1 Defects in MDS/AML with 3q21q26 Abnormalities.. Blood. 110(11). 4224–4224. 1 indexed citations
9.
Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2006). Clinical Relevance of Cytogenetics in Myelodysplastic Syndromes. Annals of the New York Academy of Sciences. 1089(1). 395–410. 25 indexed citations
10.
Bernasconi, Paolo, Silvia Calatroni, Ilaria Giardini, et al.. (2005). ABL1 amplification in T-cell acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 162(2). 146–150. 17 indexed citations
11.
Bernasconi, Paolo, Catherine Klersy, Marina Boni, et al.. (2005). Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution. Leukemia. 19(8). 1424–1431. 59 indexed citations
12.
Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2004). Molecularly Targeted Therapy in Acute Myeloid Leukemia. Annals of the New York Academy of Sciences. 1028(1). 409–422. 8 indexed citations
13.
Bernasconi, Paolo, Silvia Calatroni, Ilaria Giardini, et al.. (2004). Amplification of the ABL Gene in T-Cell Acute Lymphoblastic Leukemia (T-ALL).. Blood. 104(11). 1083–1083. 1 indexed citations
14.
Bernasconi, Paolo, Paola Maria Cavigliano, Marina Boni, et al.. (2003). Is FISH a relevant prognostic tool in myelodysplastic syndromes with a normal chromosome pattern on conventional cytogenetics? A study on 57 patients. Leukemia. 17(11). 2107–2112. 47 indexed citations
15.
Bernasconi, Paolo, Marina Boni, Paola Maria Cavigliano, et al.. (2002). Molecular Genetics of Acute Myeloid Leukemia. Annals of the New York Academy of Sciences. 963(1). 297–305. 9 indexed citations
16.
Bernasconi, Paolo, Paola Maria Cavigliano, Marina Boni, et al.. (2002). Long‐term follow up with conventional cytogenetics and band 13q14 interphase/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance. British Journal of Haematology. 118(2). 545–549. 12 indexed citations
17.
Bernasconi, Paolo, Marina Boni, Silvia Calatroni, et al.. (2002). Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea. Leukemia. 16(10). 2078–2083. 26 indexed citations
18.
Bernasconi, Paolo, Paola Maria Cavigliano, Marina Boni, et al.. (2000). Trisomy 11 and a Complex t(11;11;22) in a Patient with Acute Myelomonocytic Leukemia (AML-M4) Following Myelodysplasia (MDS). Cancer Genetics and Cytogenetics. 116(2). 111–118. 4 indexed citations
19.
Bernasconi, Paolo, Ester Orlandi, Paola Maria Cavigliano, et al.. (2000). Translocation (8;16) in a patient with acute myelomonocytic leukemia, occurring after treatment with fludarabine for a low-grade non-Hodgkin's lymphoma.. PubMed. 85(10). 1087–91. 12 indexed citations
20.
Bernasconi, Paolo, Paola Maria Cavigliano, Emilia Genini, et al.. (1998). A Complex Translocation (5;7) in a Patient with Acute Nonlymphocytic Leukemia Evolved from a Myelodysplastic Syndrome. Cancer Genetics and Cytogenetics. 105(2). 182–186. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Rocca Breakdown of academic impact, for papers by Paola Maria Cavigliano Breakdown of academic impact, for papers by Michael Heinsch Breakdown of academic impact, for papers by G.W. Dewald Breakdown of academic impact, for papers by V. Parlier Breakdown of academic impact, for papers by Laurence Baranger Breakdown of academic impact, for papers by Magda Šišková Breakdown of academic impact, for papers by Jörg Chromik Breakdown of academic impact, for papers by Simone Feurstein Breakdown of academic impact, for papers by Chad P. Soupir
Rankless by CCL
2026